Through the development of new treatment methods, research and data products, Alv B will create value for our shareholders.
If you’re interested in investing in Alv B, we’re interested in talking to you.
We're about to launch our first vaccines in partner clinics for a clinical trial. In conjunction with that, we are seeking investors to help us along on our journey.
Get in touch through our contact form to announce your interest, and you will hear from us.
We look forward to hearing from you
We look forward to hearing from youCONTACT US